Skip to content

HFCS, Apple Juice, Excess Free Fructose & asthma-the FHS-OS

Moderate Intake of High Fructose Corn Syrup Sweetened Soft Drinks, Fruit Drinks and Apple Juice Increases Asthma Risk - the Framingham Offspring Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03189251
Enrollment
2657
Registered
2017-06-16
Start date
1971-06-30
Completion date
Unknown
Last updated
2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Perform an exploratory analysis of association between consumption of high excess free fructose (EFF) beverages (high fructose corn syrup sweetened soft drinks, fruit drinks, apple juice) and Chronic Bronchitis (CB)/history of CB, and asthma/ history of asthma.

Interventions

Analysis of association between consumption of high excess free fructose (EFF) beverages (high fructose corn syrup sweetened soft drinks, fruit drinks, apple juice)

Sponsors

Jaime Uribarri, M.D.
CollaboratorUNKNOWN
Katherine L. Tucker, Ph.D.
CollaboratorUNKNOWN
Luanne R DeChristopher
Lead SponsorINDIV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants in the FHS Offspring who answered questions in the FFQ about soft drinks, fruit drinks and fruit juice consumption; Participants with non-missing data for the exposures and potentially confounding variables of interest.

Exclusion criteria

* Extreme energy intake on food frequency questionnaire (defined as ≤600 kcal/day or ≥4800 kcal/day)

Design outcomes

Primary

MeasureTime frameDescription
AsthmaExams 3 - 7, 17 years of follow-upIncident asthma defined as self-reported asthma (at each exam), including wheezing or asthma (have you had asthma/ wheeze since the last exam of short duration, long duration or with respiratory infections)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026